Company intelligence / Profile preview
Shanghai Yitai Pharmaceutical
- Ownership
- Private
- Development stage
- Other
Overview
Shanghai Yitai Pharmaceutical Technology is a biotechnology company specializing in the development of radiopharmaceuticals and innovative therapeutics for oncology, osteoporosis, and endocrine diseases. Acquired by Yantai Dongcheng Pharmaceutical Group in 2016, the company focuses on bone-targeted radionuclide therapies and diagnostic tracers. Its lead programs include Rhenium-188 HEDP for painful bone metastases and a synthetic peptide analog of human parathyroid hormone-related protein for osteoporosis. The company also collaborates on advanced PET imaging agents like Florzolotau for neurodegenerative diseases and operates a specialized GMP nuclear pharmacy in Shanghai.
- Therapeutic areas
- OncologyEndocrinologyNeurology
- Modalities
- RadiopharmaceuticalPeptidesSmall molecule
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Shanghai Yitai Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shanghai Yitai Pharmaceutical.